Pharmaceutical Contract Research Organization Market

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Pharmaceutical Contract Research Organization Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Pharmaceutical Contract Research Organization Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Pharmaceutical Contract Research Organization Market, Segment By Type
   1. Introduction
      1. Market Size and Forecast, Segment By Type
   2. Active Pharmaceutical Ingredient
      1. Market Size and Forecast, By Region
   3. Finished Dosage Formulation
      1. Market Size and Forecast, By Region
10. Pharmaceutical Contract Research Organization Market, Segment By Application
    1. Introduction
       1. Market Size and Forecast, Segment By Application
    2. Pharmaceutical and Biopharmaceutical Companies
       1. Market Size and Forecast, By Region
    3. Medical Device Companies
       1. Market Size and Forecast, By Region
    4. Academic Institutes
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. North America
       1. Market Size and Forecast
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       2. U.S.
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       3. Canada
    3. Europe
       1. Market Size and Forecast
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       2. U.K.
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       3. Germany
       4. France
       5. Spain
       6. Italy
       7. Russia
       8. Nordic
       9. Benelux
       10. Rest of Europe
    4. APAC
       1. Market Size and Forecast
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       2. China
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       3. Korea
       4. Japan
       5. India
       6. Australia
       7. Singapore
       8. Taiwan
       9. South East Asia
       10. Rest of Asia-Pacific
    5. Middle East and Africa
       1. Market Size and Forecast
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       2. UAE
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       3. Turky
       4. Saudi Arabia
       5. South Africa
       6. Egypt
       7. Nigeria
       8. Rest of MEA
    6. LATAM
       1. Market Size and Forecast
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       2. Brazil
          1. Segment By Type
             1. Active Pharmaceutical Ingredient
             2. Finished Dosage Formulation
          2. Segment By Application
             1. Pharmaceutical and Biopharmaceutical Companies
             2. Medical Device Companies
             3. Academic Institutes
       3. Mexico
       4. Argentina
       5. Chile
       6. Colombia
       7. Rest of LATAM
12. Competitive Landscape, 2023
    1. Introduction
    2. Pharmaceutical Contract Research Organization Market Share Analysis, 2023 (%)
       1. Market Share Analysis, 2023
       2. Competition Ranking, 2023
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. IQVIA
       1. Business Overview
       2. Financial Data
       3. Key Product Categories
       4. Recent Developments
    2. Syneos Health
    3. Quintiles
    4. PPD
    5. Parexel
    6. ICON
    7. PRA Health Sciences
    8. InVentiv
    9. INC Research Holdings
    10. CRL
    11. Wuxi AppTec
    12. Charles River
    13. Envigo
    14. Medpace Holdings
    15. SGS
    16. PSI CRO
    17. Axcent Advanced Analytics
    18. BIO Agile Therapeutics
    19. Firma Clinical Research
    20. Acculab Lifesciences
    21. Azelix
    22. CTSERV
    23. PEPGRA